Patent Assignment
Reel/Frame 016570/0324
Merger
Recorded: 2005-09-22
Pages: 43
Assignor
YAMANOUCHI PHARMACEUTICAL CO., LTD.
Executed: 2005-04-07
Assignee
ASTELLAS PHARMA INC.
3-11, NIHONBASHI-HONCHO 2-CHOME, CHUO-KU, TOKYO, 103-8411, JAPAN
Covered Properties
(98)
Intrabuccally Dissolving Compressed Moldings and Production Process Thereof
Patent:
5,576,014 →
Application:
08/385,093 →
Hydrogel-Forming Sustained-Release Preparation
Patent:
6,436,441 →
Application:
08/403,752 →
Morpholine Derivative
Patent:
5,521,180 →
Application:
08/495,619 →
Novel Bisoxadiazolidine Derivative
Patent:
5,643,931 →
Application:
08/537,907 →
Condensed Benzazepine Derivative and Pharmaceutical Composition Thereof
Patent:
5,723,606 →
Application:
08/586,686 →
1,2,3,4-Tetrahydroquinoxalinedione Derivative
Patent:
6,096,743 →
Application:
08/809,087 →
Azole Derivative with Leukotriene(Lts) Antagonizing Activity and Thomb Thomboxane(Tx) A2 Antagonizing Activity
Patent:
5,981,559 →
Application:
08/809,466 →
Bone-Forming Graft
Patent:
5,830,493 →
Application:
08/817,409 →
Quinuclidine Derivatives and Medicinal Composition Thereof
Patent:
6,017,927 →
Application:
08/860,377 →
Condensed Benzazepine Derivative and Pharmaceutical Composition Thereof
Patent:
5,856,564 →
Application:
08/972,271 →
Inhibitor of Kainic Acid Neurotoxicity and Pyridothiazine Derivative
Patent:
6,133,258 →
Application:
09/068,534 →
H2-Receptor Antagonist and Antacid Composition
Patent:
6,090,412 →
Application:
09/077,186 →
Imidazole-Substituted Quinoxalinedione Derivatives
Patent:
6,121,264 →
Application:
09/194,750 →
Novel Quinuclidine Derivatives and Medicinal Composition Thereof
Patent:
6,174,896 →
Application:
09/312,392 →
Anti-Helicobacter Pyloripharmaceutical Composition
Patent:
6,184,230 →
Application:
09/423,924 →
Tricyclic Pyrrole or Pyrazole Derivative
Patent:
6,245,796 →
Application:
09/445,104 →
Medicinal Compositions with Cholesterol-Lowering Effect
Patent:
6,300,364 →
Application:
09/463,334 →
Pharmaceutical compound comprising a pyrazole derivative and methods of using the same for the treatment of calcium release- activated calcium channel associated diseases
Patent:
6,348,480 →
Application:
09/529,131 →
Novel Pyrimidine-5-Carboxamide Derivatives
Patent:
6,432,963 →
Application:
09/581,595 →
Brain Specific Potassium Channel Protein
Patent:
6,326,168 →
Application:
09/600,776 →
Polynucleotides Encoding Sre B2 Receptor
Patent:
6,555,344 →
Application:
09/622,439 →
Hydrogel-Forming Sustained-Release Preparation
Patent:
6,699,503 →
Application:
09/702,880 →
Pyrazole Derivative
Cyanophenyl Derivative
Patent:
6,673,799 →
Application:
09/787,672 →
Medicinal Compositions for Treating Osseous Lesion in Multiple Myeloma
Patent:
6,727,233 →
Application:
09/869,122 →
Novel Depsipeptide Compound
Patent:
6,670,326 →
Application:
09/889,303 →
Novel Thiazolobenzimidazole Derivatives
Patent:
6,642,264 →
Application:
09/958,174 →
Methods of Screening for Modifiers of Potassium Channel Protein Activity
Peptide Leukotriene Receptor
Patent:
6,878,525 →
Application:
09/979,603 →
Novel Heterocyclecarboxamide Derivative
Patent:
6,797,706 →
Application:
10/009,276 →
Novel Metalloprotease Having Aggrecanase Activity
Patent:
6,716,613 →
Application:
10/009,332 →
Pharmaceutical Composition for Oral Use
Patent:
6,525,058 →
Application:
10/009,797 →
Remedies for Neurogenic Pain
Patent:
6,664,283 →
Application:
10/031,404 →
Bitterness-Reduced Intrabuccally Quick Disintegrating Tablets and Method for Reducing Bitterness
Bitterness-Reduced Oral Pharmaceutical Composition
Naphthyridine Derivatives
Patent:
6,740,662 →
Application:
10/111,077 →
Remedies for Periodontosis
Patent:
6,682,718 →
Application:
10/130,795 →
Fused Imidazolium Derivatives
Medicinal compositions for suppressing beta-amyloid production
Application:
10/169,580 →
Publication:
US 2003/0100477
Rapidly Disintegrable Pharmaceutical Composition
Human pgc-1 promoter
Application:
10/220,760 →
Publication:
US 2004/0115626
Propane-1,3-Dione Derivative
Polynucleotides Encoding SREB3 Receptor
Hydrogel-forming sustained-release preparation
Application:
10/323,810 →
Publication:
US 2003/0203024
Novel Clock Gene Promoter
Amide Derivative
Famotidine Injections
Thiopeptide Compounds
Antitumor agents
Application:
10/476,539 →
Publication:
US 2004/0138207
Phenylpyridinecarbonylpiperazine Derivative
Sustained-release compositions for injection and process for producing the same
Application:
10/480,929 →
Publication:
US 2004/0142043
Novel screening method using prokineticin receptor
Application:
10/490,023 →
Publication:
US 2004/0241757
Novel Polypeptide
Method of Screening Cell Death Inhibitor
Transgenic Animals
Method for screening a drug ameliorating insulin resistance
Application:
10/502,279 →
Publication:
US 2005/0084840
2,4,6-Triamino-1,3,5-Triazine Derivative
Nitrogen-containing heterocyclic compound
Application:
10/505,939 →
Publication:
US 2005/0096322
Aminomethyl-Substituted Thiazolobenzimidazole Derivative
Angiopoietin-related growth factors
Application:
10/509,378 →
Remedy for Glioblastoma
Novel promoter
Application:
10/509,565 →
Publication:
US 2006/0014931
Novel Oxidase
Novel crystal of quinoxalinedione derivative anhydride
Application:
10/511,089 →
Publication:
US 2005/0130978
Tetrahydropyran derivative
Application:
10/514,636 →
Publication:
US 2005/0239780
Method of screening remedy for renal failure
Application:
10/516,517 →
Publication:
US 2005/0233304
Overactive bladder treating drug
Application:
10/517,137 →
Publication:
US 2006/0035923
Diaminopyrimidinecarboxamide Derivative
Therapeutic agent for brain hemorrhage
Application:
10/519,353 →
Publication:
US 2005/0234063
Method for screening an agent for improving insulin resistance
Application:
10/519,447 →
Publication:
US 2005/0244829
N-Phenyl-(2R,5S) Dimethylpiperazine Derivative
Novel genes relating to chronic rheumatoid arthritis
Application:
10/521,940 →
Publication:
US 2006/0172296
Novel serine protease
Application:
10/522,668 →
Publication:
US 2006/0134719
Apparatus for forming molecular timetable and apparatus for estimating circadian clock
Application:
10/522,735 →
Publication:
US 2006/0078883
Arthrodial cartilage extracellular matrix degradation inhibitor
Application:
10/525,015 →
Publication:
US 2005/0272647
Novel Crystals
Novel Depsipeptide Compound
Hypogastric and/or perineal pain-relieving agent
Application:
10/526,377 →
Publication:
US 2006/0063842
Cap-Binding Protein
Remedy for Overactive Bladder Comprising Acetic Acid Anilide Derivative as the Active Ingredient
Protein Which Binds to AKT2
Novel denzamide derivatives and process for production thereof
Application:
10/540,421 →
Publication:
US 2006/0084807
Cyanophenyl derivative
Application:
10/608,341 →
Publication:
US 2004/0010037
Pharmaceutical Compositions for Treating Bone Lesions in Multiple Myeloma
Novel Depsipeptide Compound
Novel metalloprotease having aggrecanase activity
Application:
10/763,210 →
Publication:
US 2004/0142445
Triazole Derivative
Polynucleotides Encoding SREB1 Receptor
Tetrahydro-2H-Thiopyran-4-Carboxamide Derivative
Peptide Leukotriene Receptor
Rapidly Disintegrable Pharmaceutical Composition
Novel leukotriene, B4 receptor
Application:
11/012,199 →
Publication:
US 2005/0159355
Parenteral pharmaceutical composition containing humanized monoclonal antibody fragment and stabilizing method thereof
Application:
11/028,037 →
Publication:
US 2005/0118167
Novel Salts of Quinuclidine Derivative
Pyrazole Derivative
Propane-1, 3-Dione Derivative
Novel clock gene promoter
Application:
11/176,253 →
Publication:
US 2005/0262579
Nitrogen-Containing Heterocyclic Compound
Related Assignments
(25)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Feb 1, 1995
From: MIZUMOTO, TAKAO; MASUDA, YOSHINORI; FUKUI, MUNEO
To: YAMANOUCHI PHARMACEUTICAL CO., LTD.
Reel/Frame 007359/0663 →
Assignment of Assignor's Interest
Mar 20, 1995
From: SAKO, KAZUHIRO; NAKASHIMA, HIROSHI; SAWADA, TOYOHIRO; OKADA, AKIRA
To: YAMANOUCHI PHARMACEUTICAL CO., LTD.
Reel/Frame 007449/0072 →
Assignment of Assignor's Interest
Aug 3, 1995
From: FUJII, MITSUO; SUZUKI, TAKAYUKI; HAYASHIBE, SATOSHI; TSUKAMOTO, SHIN-ICHI
To: YAMANOUCHI PHARMACEUTICAL CO., LTD.
Reel/Frame 007683/0087 →
Assignment of Assignor's Interest
Oct 26, 1995
From: NIIGATA, KUNIHIRO; TAKAHASHI, TAKUMI; MARUYAMA, TATSUYA; SUZUKI, TAKAYUKI
To: YAMANOUCHI PHARMACEUTICAL CO., LTD.
Reel/Frame 007763/0742 →
Assignment of Assignor's Interest
Jan 19, 1996
From: TANAKA, AKIHIRO; KOSHIO, HIROYUKI; TANIGUCHI, NOBUAKI; MATSUHISA, AKIRA
To: YAMANOUCHI PHARMACEUTICAL CO., LTD.
Reel/Frame 008713/0679 →
Assignment of Assignor's Interest
Mar 5, 1997
From: SHISHIKURA, JUN-ICHI; INAMI, HIROSHI; SAKAMOTO, SHUICHI; TSUKAMOTO, SHIN-ICHI
To: YAMANOUCHI PHARMACEUTICAL CO., LTD.
Reel/Frame 008557/0338 →
Assignment of Assignor's Interest
Mar 25, 1997
From: YOKOTA, SHOJI; SHIMOKAWA, SEITARO; SONOHARA, RITSU; OKADA, AKIRA
To: YAMANOUCHI PHARMACEUTICAL CO., LTD.
Reel/Frame 008618/0947 →
Assignment of Assignor's Interest
Aug 15, 1997
From: NAGAOKA, NORIKO, LEGAL REPRESENTATIVE/HEIR OF HITOSHI NAGAOK (DECEASED); YOKOTA, MASAKI; AKANE, HIROAKI; ARAKIDA, YASUHITO
To: YAMANOUCHI PHARMACEUTICAL CO., LTD.
Reel/Frame 008965/0663 →
Assignment of Assignor's Interest
Aug 28, 1997
From: TAKEUCHI, MAKOTO; NAITO, RYO; HAYAKAWA, MASAHIKO; OKAMOTO, YOSHINORI
To: YAMANOUCHI PHARMACEUTICAL CO., LTD.
Reel/Frame 008827/0376 →
Assignment of Assignor's Interest
May 13, 1998
From: SHISHIKURA, JUN-ICHI; INAMI, HIROSHI; YASUNAGA, TOMOYUKI; HIRANO, MASAAKI
To: YAMANOUCHI PHARMACEUTICAL CO., LTD.
Reel/Frame 009594/0148 →
Assignment of Assignor's Interest
May 26, 1998
From: HASHIMOTO, YOSHIMI; SHIOZAWA, HIROYOSHI; KISHIMOTO, HIDEYUKI; SETOGUCHI, YOICHI
To: YAMANOUCHI PHARMACEUTICAL CO., LTD.
Reel/Frame 009376/0411 →
Assignment of Assignor's Interest
Dec 2, 1998
From: SAKAMOTO, SHUICHI; OHMORI, JUNYA; SHISHIKURA, JUN-ICHI; SASAMATA, MASAO
To: YAMANOUCHI PHARMACEUTICAL CO., LTD.
Reel/Frame 009904/0785 →
Assignment of Assignor's Interest
Dec 2, 1999
From: MAENO, KYOICHI; KAZUTA, KEN-ICHI; KUBOTA, NIDEKI; SHIMADA, ITSURO
To: YAMANOUCHI PHARMACEUTICAL CO., LTD.
Reel/Frame 010546/0509 →
Assignment of Assignor's Interest
Jan 24, 2000
From: SHIMOKAWA, TERUHIKO; NISHIJIMA, SATOMI; MATSUDA, KOYO; IIZUMI, YUICHI
To: YAMANOUCHI PHARMACEUTICAL CO., LTD.
Reel/Frame 010606/0386 →
Assignment of Assignor's Interest
Apr 7, 2000
From: KUBOTA, HIROKAZU; YONETOKU, YASUHIRO; SUGASAWA, KEIZOU; FUNATSU, MASASHI
To: YAMANOUCHI PHARMACEUTICAL CO., LTD.
Reel/Frame 010873/0588 →
Assignment of Assignor's Interest
Apr 20, 2000
From: WATANABE, MASATO; TANAKA, KOUICHI; KOMIYA, MASAYUKI; RANTIATMODJO, RATNA MURNI
To: YAMANOUCHI PHARMACEUTICAL CO., LTD.; P.T. KALBE FARMA
Reel/Frame 010763/0192 →
Assignment of Assignor's Interest
Jun 15, 2000
From: HISAMICHI, HIROYUKI; NAITO, RYO; KAWAZOE, SOUICHIROU; TOYOSHIMA, AKIRA
To: YAMANOUCHI PHARMACEUTICAL CO., LTD.
Reel/Frame 010930/0298 →
Assignment of Assignor's Interest
Jul 21, 2000
From: MIYAKE, AKIRA; MOCHIZUKI, SHINOBU; YOKOI, HIROMICHI
To: YAMANOUCHI PHARMACEUTICAL CO., LTD.
Reel/Frame 010990/0563 →
Assignment of Assignor's Interest
Aug 17, 2000
From: MATSUMOTO, MITSUYUKI; SUGIMOTO, TORU; TAKASAKI, JUN; KAMOHARA, MASAZUMI
To: YAMANOUCHI PHARMACEUTICAL CO., LTD.
Reel/Frame 011046/0491 →
Corrective Assignment Correcting the Third Assignor's Name Previously Recorded on Reel 010873, Frame 0588. Assignor Confirms the Assignment of the Entire Interest.
Feb 2, 2001
From: KUBOTA, HIROKAZU; YONETOKU, YASUHIRO; SUGASAWA, KEIZO; FUNATSU, MASASHI
To: YAMANOUCHI PHARMACEUTICAL CO., LTD.
Reel/Frame 011495/0452 →
Assignment of Assignor's Interest
Feb 2, 2001
From: KUBOTA, HIROKAZU; YONETOKU, YASUHIRO; SUGASAWA, KEIZO; FUNATSU, MASASHI
To: YAMANOUCHI PHARMACEUTICAL CO., LTD.
Reel/Frame 011518/0018 →
Assignment of Assignor's Interest
May 23, 2002
From: O'UCHI, NAOTO; IWAI, TAKAYA; YOSHINO, TAIJI; KANOH, HIROYUKI
To: YAMANOUCHI PHARMACEUTICAL CO., LTD.
Reel/Frame 013145/0258 →
Assignment of Assignor's Interest
Jul 8, 2002
From: MATSUHISA, AKIRA; KINOYAMA, ISAO; TOYOSHIMA, AKIRA; NAKAHARA, TAKAHITO
To: YAMANOUCHI PHARMACEUTICAL CO., LTD.
Reel/Frame 014082/0570 →
Merger
Aug 22, 2005
From: YAMANOUCHI PHARMACEUTICAL CO., LTD.
To: ASTELLAS PHARMA INC.
Reel/Frame 016427/0487 →
Assignment of Assignor's Interest
May 30, 2014
From: ASTELLAS PHARMA US, INC.
To: CUMBERLAND PHARMACEUTICALS INC.
Reel/Frame 032994/0603 →